Literature DB >> 10666212

Migration of activated CD8(+) T lymphocytes to sites of viral infection does not require endothelial selectins.

C Bartholdy1, O Marker, A R Thomsen.   

Abstract

Using mice deficient of E-selectin and E/P-selectin, we have studied the requirement for endothelial selectins in extravasation of leukocytes at sites of viral infection, with major emphasis on the recruitment of virus-specific T(C)1 cells. Lymphocytic choriomeningitis virus (LCMV)-induced meningitis was used as our primary experimental model. Additionally, localized subdermal inflammation and virus clearance in internal organs were analyzed during LCMV infection. The generation of CD8(+) effector T cells in infected mutants was unimpaired. Quantitative and qualitative analysis of the inflammatory exudate cells in intracerebrally infected mice gave identical results in all strains of mice. Expression of endothelial selectin was also found to be redundant regarding the ability of effector cells to eliminate virus in nonlymphoid organs. Concerning LCMV-induced footpad swelling, absent or marginal reduction was found in E/P-sel -/- mice, compared with wild-type mice after local challenge with virus or immunodominant viral MHC class I restricted peptide, respectively. Similar results were obtained after adoptive transfer of wild-type effector cells into E/P-sel -/- recipients, whereas footpad swelling was markedly decreased in P-sel/ICAM-1 -/- and ICAM-1 -/- recipients. LCMV-induced footpad swelling was completely inhibited in ICAM-deficient mice transfused with donor cell preincubated with soluble VCAM-1-Ig chimeric protein. Taken together, the current findings strongly indicate that the migration of T(C)1 effector cells to sites of viral infection can proceed in the absence of endothelial selectins, whereas ligands of the Ig superfamily are critically involved in this process. (Blood. 2000;95:1362-1369)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666212

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Subset-specific reductions in lung lymphocyte accumulation following intratracheal antigen challenge in endothelial selectin-deficient mice.

Authors:  Jeffrey L Curtis; Joanne Sonstein; Ronald A Craig; Jill C Todt; Randall N Knibbs; Timothy Polak; Daniel C Bullard; Lloyd M Stoolman
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

Review 2.  Effector CD8 T cell trafficking within the liver.

Authors:  Luca G Guidotti; Matteo Iannacone
Journal:  Mol Immunol       Date:  2012-11-10       Impact factor: 4.407

3.  ICAM-1-dependent tuning of memory CD8 T-cell responses following acute infection.

Authors:  Maureen A Cox; Scott R Barnum; Daniel C Bullard; Allan J Zajac
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

Review 4.  Immune-Mediated Hepatitis During Immune Checkpoint Inhibitor cancer Immunotherapy: Lessons From Autoimmune Hepatitis and Liver Immunology.

Authors:  Julian Hercun; Catherine Vincent; Marc Bilodeau; Pascal Lapierre
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 5.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

Review 6.  Lymphocytic choriomeningitis infection of the central nervous system.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  Front Biosci       Date:  2008-05-01

7.  Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice.

Authors:  Roberta Angioni; Bianca Calì; Vasanthy Vigneswara; Marika Crescenzi; Ana Merino; Ricardo Sánchez-Rodríguez; Cristina Liboni; Martin J Hoogduijn; Philip Noel Newsome; Maurizio Muraca; Francesco Paolo Russo; Antonella Viola
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

8.  L-selectin Is Essential for Delivery of Activated CD8(+) T Cells to Virus-Infected Organs for Protective Immunity.

Authors:  Rebar N Mohammed; H Angharad Watson; Miriam Vigar; Julia Ohme; Amanda Thomson; Ian R Humphreys; Ann Ager
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.